Margaret McLoughlin
Direktor/Vorstandsmitglied bei QUINCE THERAPEUTICS, INC.
Vermögen: 6 640 $ am 31.05.2024
Aktive Positionen von Margaret McLoughlin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| QUINCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2015 | - |
| Independent Dir/Board Member | 01.12.2015 | - |
Karriereverlauf von Margaret McLoughlin
Ehemalige bekannte Positionen von Margaret McLoughlin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2014 | 01.05.2019 |
| 4D MOLECULAR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - | 20.03.2019 |
| Yale University | Corporate Officer/Principal | 01.01.1991 | - |
| BIOATLA, INC. | Direktor/Vorstandsmitglied | - | - |
Herophilus, Inc.
 Herophilus, Inc. Packaged SoftwareTechnology Services Herophilus, Inc. operates as neurotherapeutics company. It employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. The firm combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. The company was founded by Frederic J. Kerrest, Sean Escola and Saul Kato and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | - | - |
Adapsyn Bioscience, Inc.
 Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Adapsyn Bioscience, Inc. operates as a biotechnology company focussed on the discovery and development of novel medicines. The company was founded by Nathan Magarvey and is headquartered in Hamilton, Canada. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Margaret McLoughlin
| University of California, Irvine | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Kanada | 2 |
Operativ
| Director/Board Member | 5 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| BIOATLA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Adapsyn Bioscience, Inc.
Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Adapsyn Bioscience, Inc. operates as a biotechnology company focussed on the discovery and development of novel medicines. The company was founded by Nathan Magarvey and is headquartered in Hamilton, Canada. | Health Technology |
Herophilus, Inc.
Herophilus, Inc. Packaged SoftwareTechnology Services Herophilus, Inc. operates as neurotherapeutics company. It employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. The firm combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. The company was founded by Frederic J. Kerrest, Sean Escola and Saul Kato and is headquartered in San Francisco, CA. | Technology Services |
- Börse
- Insiders
- Margaret McLoughlin
- Erfahrung
